Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity

Background: Coronavirus disease of 2019 (COVID-19) is associated with a prothrombotic state and a high incidence of thrombotic event(s) (TE). Objectives: To study platelet reactivity in hospitalized COVID-19 patients and determine a possible association with the clinical outcomes thrombosis and all-...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Chantal C., Jukema, Bernard N., Barendrecht, Arjan D., Spanjaard, Judith S., Jorritsma, Nikita K. N., Smits, Simone, de Maat, Steven, Seinen, Cor W., Verhoef, Sandra, Parr, Naomi M. J., Sebastian, Silvie A. E., Koekman, Arnold C., van Wesel, Annet C. W., van Goor, Harriet M. R., Spijkerman, Roy, Bongers, Suzanne H., van der Vries, Erhard, Nierkens, Stefan, Boes, Marianne, Koenderman, Leo, Kaasjager, Karin A. H., Maas, Coen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100661/
https://www.ncbi.nlm.nih.gov/pubmed/33968958
http://dx.doi.org/10.3389/fmed.2021.650129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100661/
https://www.ncbi.nlm.nih.gov/pubmed/33968958
http://dx.doi.org/10.3389/fmed.2021.650129

Ejemplares similares